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Abstract
UbcH10 is a component of the Ubiquitin Conjugation Enzymes (Ubc; E2) involved in the ubiquitination cascade controlling
the cell cycle progression, whereby ubiquitin, activated by E1, is transferred through E2 to the target protein with the
involvement of E3 enzymes. In this work we propose the first three dimensional model of the tetrameric complex formed by
the human UbA1 (E1), two ubiquitin molecules and UbcH10 (E2), leading to the transthiolation reaction. The 3D model was
built up by using an experimentally guided incremental docking strategy that combined homology modeling, protein-
protein docking and refinement by means of molecular dynamics simulations. The structural features of the in silico model
allowed us to identify the regions that mediate the recognition between the interacting proteins, revealing the active role of
the ubiquitin crosslinked to E1 in the complex formation. Finally, the role of these regions involved in the E1–E2 binding was
validated by designing short peptides that specifically interfere with the binding of UbcH10, thus supporting the reliability
of the proposed model and representing valuable scaffolds for the design of peptidomimetic compounds that can bind
selectively to Ubcs and inhibit the ubiquitylation process in pathological disorders.
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Introduction
UbcH10 is a member of the Ubiquitin Conjugation Enzymes, a
component of the anaphase-promoting complex and a key
regulator of cell cycle progression [1], as it induces the
ubiquitination and degradation of cyclins A and B [2]. Previous
studies have indicated that UbcH10 over-expression might be
associated with the late stages of thyroid neoplastic transformation
[3], and that high levels of UbcH10 correlate with most aggressive
grade tumors in breast cancer [4]. Similar evidences have been
found for several tumor types, such as ovarian [5], colorectal and
brain cancers [6] and different lymphoma [7]. Moreover, in
numerous cancer tissues the UbcH10 expression is relatively
higher if compared with the adjacent nonmalignant tissues. All
these evidences point out that the aberrant expression of UbcH10
could promote tumor expansion through dysfunction of mitotic
progression, leading to deregulation of cell growth as confirmed in
both thyroid [6] and breast carcinoma [8], where the interference
with the UbcH10 expression significantly reduced the tumor cell
proliferation. Therefore, UbcH10 appears to be a potential target
for developing an anti-cancer therapy based on the suppression of
its specific biological function.
A key step in the discovery of inhibitors of the UbcH10-
mediated ubiquitination is the comprehension of the structural
and mechanistic features that mediate the conjugation of proteins
to ubiquitin (Ub), a complex process that involves a three-step
cascade mechanism characterized by growing specificity ([8]; see
also ref. [9] for a recent review) (Figure 1). Thus, the Ubiquitin-
Activating Enzyme (UbA1, also known as E1) initiates the
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ubiquitination cascade by catalyzing the ATP-dependent adenyla-
tion of the Ub C-terminus (step I). The high-energy anhydride
bond thus formed is attacked by the E1 active site cysteine (C632
in human UbA1), forming a thioester bond between E1 and Ub
(step II). Then, Ub is transferred to the active site cysteine of an
Ub-Conjugation Enzyme (denoted E2), a process promoted by the
non-covalent binding of a second Ub molecule in the adenylation
site (steps III and IV). Finally, Ub is conjugated to its substrate
with the aid of a protein ligase (known as E3), resulting in the
covalent linkage of the Ub C-terminus to the e-amino group of a
lysine in the substrate (steps V and VI). In humans, there are two
E1 enzymes (UbA1 and UbA6) [10], over 30 distinct forms of E2
and about 500–1000 forms of E3, which is largely responsible for
conferring specificity to ubiquitylation [11].
The preceding mechanism is common to the Ubiquitin-like
proteins (Ubl), a class of signaling proteins involved in cellular
homoeostasis [12]. A number of X-ray and NMR studies
(reviewed in [12–14]) have examined the structural features of
the recognition between Ub and Ubl (SUMO and NEDD8) with
E1, while only few studies were focused on the E1–E2 interaction,
including the complex between APPBP1-Uba3,NEDD8/
NEDD8/MgATP/Ubc12 [13], and the construct obtained by
crosslinking the catalytic cysteines of the UbA1,Ubc4/MgATP
[14]. While they reveal a general preservation of the E1 structure,
they have disclosed the existence of significant structural differ-
ences, particularly in the SCCH (Second Catalytic Cysteine Half-
domain) and UFD (Ubiquitin Folding Domain) regions, which
highlight the intrinsic flexibility of E1 for accommodating both Ub
and E2. However, to the best of our knowledge, there is not a
complete 3D model of the quaternary complex required for the
transfer of Ub to the E2 Ubiquitin Conjugation Enzyme.
In this paper we describe a computational and experimental
strategy to build up the first structural model of the transient
tetrameric complex between the doubly Ub-loaded human UbA1
(hereafter denoted UbA1,Ub(T)-Ub(A)), and UbcH10, as a
member of the E2 family. By combining homology modeling,
protein-protein docking and molecular dynamics (MD) simulations,
the structural features of the proposed model have allowed us to
identify the regions that mediate the recognition between the
interacting proteins. In turn, this information has been used to
examine the reliability of the structural model through experimental
assays performed to evaluate the binding affinities of a number of
short peptides that were suitably chosen from the contact regions
between interacting partners in the complex. Overall, this
information can be valuable to gain insight into the specificity of
the recognition between E1 and E2 partners, as well as for the
design of peptidomimetic compounds that can bind selectively to
E2s and inhibit the ubiquitylation process in pathological disorders.
Materials and Methods
Homology building
The amino acid sequence of human UbA1 (hUbA1) was
retrieved from the National Center for Biotechnology Information
(http://www.ncbi.nlm.nih.gov; accession ID P22314). To find
suitable templates for homology modelling, a BLASTP [15] search
was performed against the Protein Data Bank (PDB) [16]. At the
beginning of this work, the search identified three templates: i) the
crystal structure of mouse Ubiquitin-Activating Enzyme (PDB
code 1Z7L; 2.8 A˚ resolution) [17], which covers 25% of the query
sequence corresponding to the SCCH domain (sequence identity
of 96%), ii) the crystal structure of the Saccharomyces cerevisiae
UbA1 (scUbA1) - Ub complex (PDB code 3CMM; 2.7 A˚
resolution) [18], which covers 98% of the query sequence
(sequence identity of 53%; similarity 71%), and iii) the NMR
solution structure of a fragment of mouse UbA1 (PDB code 2V31)
[19], which covers 10% of the query sequence corresponding to
the FCCH region, with sequence identity of 93%. This latter
Figure 1. Ubiquitin conjugation cascade. UbA1 consists of four domains: the Adenylation domain (AD), the First Catalytic Cysteine Half-domain
(FCCH), the Second Catalytic Cysteine Half-domain (SCCH) and the Ubiquitin Folding Domain (UFD). I) UbA1 catalyzes the adenylation of the Ub C-
terminus in an ATP-dependent process in the AD domain; II) the activated Ub forms a thioester bond with a conserved catalytic cysteine in the SCCH
domain of UbA1 [Ub(T)]; III) UbA1 is loaded with a second Ub molecule in the AD domain, followed by its C-terminal adenylation [Ub(A)]; IV) the
ternary UbA1,Ub(T)-Ub(A) thioester complex recruits E2 (e.g. UbcH10); V) the thioester-linked Ub is transferred to a conserved E2 cysteine
(transthioesterification); VI) E3 mediates the binding of Ub to the target lysine e-amino groups.
doi:10.1371/journal.pone.0112082.g001
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structure showed that only the core region of FCCH was
structured. Therefore, homology building was accomplished by
using 1Z7L as template for the hUbA1 SCCH region (residues
629–884; hUbA1 numbering will be followed unless otherwise
noted), and 3CMM as template for the AD, FCCH and UFD
domains (residues 1–628 and 885–1057). Finally, since chains A
and C in the X-ray structure 3CMM differ by a rigid-body
rotation of the UFD domain, hUbA1 was modeled using the two
monomers, leading then to two models hereafter designated
UbA1_A and UbA1_C.
The ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/)
[20] program was used for sequence alignment. The 3D structure
of the target protein was modeled using SWISSMODEL [21]. The
secondary structure of the target protein was assigned using DSSP
[22]. Coordinates for two loops with undetermined coordinates in
the UbA1 template structure (residues 812–824 and 964–969)
were built up using the loop building ProMod tool [23] by
scanning through the loop database in SWISSMODEL. The
models were refined on the basis of energy minimization by
GROMOS96 [24] and the models were validated for the 3D–1D
profile with VERIFY3D [25], non-bonded interactions with
ERRAT2 [26] and stereochemical qualities with PROCHECK
[27] and WHATCHECK [28]. The comparison of the final
model with the recently released structure of Schizosaccharomyces
Pombe UbA1 (spUbA1; PDB code 4II3) revealed similar homology
parameters with hUbA1 (covered sequence 94%; sequence
identity of 54%; similarity 70%) and a RMSD for the backbone
atoms of 1.6 A˚, thus confirming the reliability of the model.
General strategy for docking calculations
The 3D model of the quaternary complex between hUbA1, two
Ub molecules and UbcH10 was determined by using an
experimentally-guided incremental strategy that relies on the
building and refinement of models for the dimeric and trimeric
complexes. Thus, we first explored the recognition between
hUbA1 and Ub, leading to the UbA1,Ub(T) complex (Ub(T)
stands for Ub bound to E1 through a thioester bond). Next, this
model was used to build up the ternary UbA1,Ub(T)-Ub(A)
system (Ub(A) denotes Ub bound to the AD domain). Finally, this
model was the starting point for assembling the quaternary
complex, UbA1,Ub(T)-Ub(A)/UbcH10. To this end, we adopted
a computational approach that combines protein-protein docking,
guided by the available structural information, and subsequent
refinement through MD simulations (see below).
In order to generate the structural models, two docking programs
were used: HADDOCK [29] and RosettaDock [30]. HADDOCK
uses experimentally derived data, in conjunction with the available
structures, to carry out flexible data-driven docking of proteins.
Residues that are known to be implicated in the protein-protein
recognition are designated active and are used to introduce suitable
restraints to drive the docking process (i.e, the so called ambiguous
interactions restraints; AIRs). HADDOCK expert interface was
used to generate a reasonable rough complex, which was
subsequently refined with the HADDOCK refinement interface.
To assess the initial orientation of the interacting partners in
order to check the suitability of the restraints to be imposed in
HADDOCK calculations (i.e., the extension and solvent accessi-
bility of the region comprising passive residues, which are solvent-
exposed residues that surround the active ones) the mutual
complementarity of the interacting partners was first explored by
superposing the structures of Uba1 and Ub(T) in the X-ray
structure of the APPBP1-Uba3,NEDD8-NEDD8-Ubc12 com-
plex [13] (PDB entry 2NVU). A list of the restraints used in
calculations is given in Supporting Information (Table S1).
Finally, the RosettaDock server performs a local docking
searching for conformations near the starting 3D structure in
order to find the optimal fit between the partners. It was then used
to calibrate the models derived from HADDOCK.
The UbA1,Ub(T)-Ub(A)-UbcH10 complex
Following the incremental docking strategy, the dimeric
UbA1,Ub(T) system was generated using as input structures
the previously generated hUbA1_A and hUbA1_C models, and
the NMR structure of human Ub (PDB ID 2K6D) [32]. For
HADDOCK calculations, the active residues were only those
involved in covalent interactions, i.e. UbA1 Cys632 and Ub
Gly76, and passive residues were defined as neighboring residues
in a range of 8.5 A˚ from the active ones. Residues in the Ub tail
(residues 70–76) and in the loop above the catalytic cysteine,
whose coordinates were undetermined in template structures
(residues 803–819), were set as fully flexible during all stages of the
docking protocol. Since RosettaDock accepts a maximum of 600
residues, docking was performed using a truncated form of UbA1
that retains the residues pertaining to the interaction domain.
Taking into account that RosettaDock allows the sliding of
proteins around 8 A˚, a binding region that includes residues 216–
296 and 627–888 was defined.
The ternary complex was generated taking into account
experimental information taken from the PDB structure 3CMM,
in which Ub is bound to the AD domain of scUbA1. In
HADDOCK calculations the active residues were those known to
participate in the binding between UbA1 (Arg239, Asp576,
Tyr600) and Ub (Asp32, Arg72, Gly75, Gly76). Passive residues
were automatically defined as neighbors in a range of 8.5 A˚ from
active residues. Besides the Ub tail, full flexibility was also given to
residues of the UbA1 crossover loop (residues 592–630) to facilitate
the accommodation of the Ub tail.
Finally, to build up the 3D model of the quaternary complex,
the UbcH10 structure was taken from PDB ID 1I7K. Let us note
that this structure is functionally active even though it lacks the
first 30 residues at the N-terminus [33]. Note also that Ser114 in
the crystal structure was mutated to Cys to restore the native
sequence. In order to enhance the sampling in predicting the
quaternary complex, four starting structures of the UbA1,Ub(T)-
Ub(A) complex were generated by combining the two UbA1
models (UbA1_A and UbA1_C) with two orientations of Ub in the
UbA1,Ub(T)complex (denoted Ha and Hb; see below). Hence, a
total of four ternary models were used to build up the 3D structure
of the quaternary complex. Active residues in HADDOCK
calculations comprised those involved in E1–E2 interactions on
the basis of mutagenesis studies [13,31,41–43]: Glu1037, Asp1047
and Glu1049 in UbA1 (numbering for the UbA1-Ub2 complex),
and Lys339 and Gln379 in UbcH10. Moreover, the two catalytic
cysteine residues (Cys632 in UbA1 and Cys1149 for UbcH10)
involved in the transthiolation process were also treated as active
residues in order to guide the complex formation. Passive residues
were defined as neighbors in a range of 8.5 A˚ from active residues.
Residues of the UbA1 crossover loop (residues 592–630) and the
Ub tail (residues 70–76) were also flexible. Each ternary model was
docked twice with UbcH10 structure yielding a total of 80 clusters.
Molecular Dynamics
MD simulations were performed to refine the different
complexes. To this end, each complex was immersed in a pre-
equilibrated octahedral box of TIP3P water molecules, and the
system was neutralized. The final systems contained between
93000 and 99000 atoms. All simulations were performed with the
parmm99SB force field [34]. The thioester bond between Ub(T)
Structural Model of the hUbA1-UbcH10 Complex
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Gly76 and UbA1 Cys362 was manually added, and suitable force
field parameters were derived using CH3CH2SCOCH3 as a
representative model. The AMP position was derived from the
ATP molecule as found in the PDB structure 2NVU. To this end,
the AD domain of the UbA1,Ub(T)-Ub(A) model was superim-
posed to the AD domain of NAE1/UbA3. On the other hand, the
phosphodiester bond between Ub(A) Gly76 and AMP was
manually added, and the force field parameters for the
phosphodiester linkage between UbA1 Cys632 and Ub(T) Gly76
were derived using CH3OP(O)2OCOCH3 as a model system.
For each complex the geometry was minimized in four steps,
which involve: i) water molecules and counterions (3000 steps of
steepest descent and 7000 steps of conjugate gradient), ii) hydrogen
atoms in the protein (500 steps of steepest descent and 4500 steps
of conjugate gradient), iii) then, hydrogen atoms, water molecules
and counterions (3500 steps of steepest descent and 11500 steps of
conjugate gradient, and iv) finally the whole system (2500 steps of
steepest descent and 8500 steps of conjugate gradient). Thermal-
ization of the system was performed in four steps of 60 ps,
increasing the temperature from 50 to 298 K. Concomitantly, the
atoms that define the protein backbone were restrained during
thermalization using a variable restraining force. Thus, a force
constant of 20 kcal.mol21 A˚22 was used in the first stage of the
thermalization and was subsequently decreased by increments of
5 kcal.mol21 A˚22 in the next stages. Then, an additional step of
250 ps was performed in order to equilibrate the system density at
constant pressure (1 bar) and temperature (298 K). Finally, an
extended trajectory was run using a time step of 2 fs. SHAKE was
used for those bonds containing hydrogen atoms in conjunction
with periodic boundary conditions at constant pressure and
temperature, particle mesh Ewald for the treatment of long range
electrostatic interactions, and a cutoff of 10 A˚ for nonbonded
interactions. The structural analysis was performed using in-house
software and standard codes of Amber 12.
Steered Molecular Dynamics and refinement of the final
complex
Comparison of the final MD structures and the recently solved
X-ray structure of Uba1 in complex with Ubc4 (PDB entry 4II2;
[14]) showed that the loop masking the hUbA1 catalytic cysteine
(Cys-cap loop) prevented a close packing between UbcH10 and
the ternary complex. Accordingly, the protein-protein interface
was refined by means of steered molecular dynamics (SMD)
simulations, which were set up using Amber 12. To this end, the
Cys-cap loop (residues 801–825) was deleted and capping groups
were added to the newly formed terminals. The distance between
the sulfur atom of the UbcH10 catalytic cysteine (C114) and the
carbon atom of the terminal carboxy group of Ub(T) was
constrained to 3 A˚ in 4 steps: i) from the initial distance (9.4 A˚)
to 7 A˚ in 0.5 ns with a force constant of 5 kcal/mol; ii) from 7 to
4 A˚ in 1.5 ns with a force constant of 5 kcal/mol; iii) from 4 to 3 A˚
in 2 ns with a force constant of 10 kcal/mol; iv) and finally from 3
to 2.5 A˚ in 4 ns with a force constant of 20 kcal/mol. At the end,
the system was rebuilt by adding the removed Cys-cap loop (UbA1
residues 801–825), equilibrated with suitable constraints in order
to relax the residues in the Cys-cap loop, and finally subjected to
an unrestrained MD (50 ns) simulation.
Binding free energy evaluation and virtual alanine
scanning
Binding free energies of the docking solutions and sampled in
MD simulations were estimated using the Solvated Interaction
Energy (SIE) method [35], as implemented in the Sietraj program
[36]. Analysis of the MD trajectory was carried out by calculating
SIE on a 0.1 ns interval at the end of the trajectory. On the other
hand, the contribution of specific residues to the binding between
interacting proteins was examined by using alanine scanning
[37,38].
GST-UbcH10 preparation for experimental binding assays
The PCR product was cloned into pGEX-4T1 expression
vector (GE Healthcare), leading to a protein with a cleavable N-
terminal GST tag (GST-UbcH10). E. coli BL21 (DE3) RP strain
was transformed with the recombinant plasmid for GST-UbcH10.
Overnight cultures were used to inoculate 500 ml LB medium
containing 50 mg/ml ampicillin, and protein induction was
performed by the addition of 1 mM IPTG at 22uC when an
OD600 value of 0.7 was reached. After approximately 16 h the
cells were harvested and the proteins were isolated by sonicating
cell pellets resuspended in 30 ml PBS1X in the presence of an
EDTA free protease inhibitor cocktail (Roche Diagnostics). The
crude cell extract was cleared by centrifugation at 18000 rpm and
the supernatant was loaded onto a 1 ml GST-trap column
connected to AKTA FPLC system (GE-Healthcare) equilibrated
with binding buffer PBS1X. After washing with ten volumes of
binding buffer, a single elution step was performed with 50 mM
TrisHCl, 10 mM reduced glutathione. The fractions containing
GST-UbcH10 were pooled and extensively dialyzed against
PBS1X at 4uC. The homogeneity of the protein was tested by
SDS–PAGE and mass spectrometry.
Peptides synthesis
A series of peptides chosen to mimic specific regions of the
protein-protein interface (L1, L2, U1 U2, S1 and S2), as well as
the L2- scrambled (ScrL2) and U1-scrambled (ScrU1) peptides
were obtained by Fmoc solid-phase strategy. To mimic the
fragment within the parent protein, the N- and C-terminus were
acetylated and amidated, respectively. The syntheses were carried
out with Novasyn TGR resin (substitution 0.25 mmol g21).
Coupling reactions were performed by using 10 equiv of Fmoc
protected amino acids activated in situ with HBTU (9.8 equiv)/
HOBt (9.8 equiv)/DIPEA (20 equiv) in DMF for 1 h. Fmoc
protecting group was removed by treatment with 30% piperidine
in DMF two times for 10 min. Before the cleavage from the resin,
all peptides were acetylated or biotinylated at the N-terminus to
obtain the corresponding derivatives. The acetylation reaction was
carried out two times for 10 min using a solution of acetic
anhydride (0.5 M)/DIPEA (0.15 M)/HOBt (0.125 M) in DMF.
Biotinylated peptides were obtained using a solution of N-(+)-
biotinyl-6-aminocaproic acid (2 equiv)/PyBop (2 equiv)/DIPEA (4
equiv) in DMF overnight. All peptides were cleaved off the resin by
treatment with a mixture of TFA/H2O/ethanedithiol (EDT)/
triisopropylsilane (TIS) (94:2.5:2.5:1v/v/v/v) for 3 h at room
temperature. The resins were filtered and the crude peptides were
precipitated with diethyl ether, dissolved in a H2O/CH3CN
(1:1 v/v) solution and lyophilized.
L1, L2, L2-scrambled, U2, S1 and S2 peptides were purified by
preparative RP-HPLC on a Shimadzu system equipped with the
UV-Vis detector SPD10A using a Phenomenex Jupiter Proteo
column (21.26250 mm; 4 mm; 90 A˚) and a linear gradient of H2O
(0.1% TFA)/CH3CN (0.1% TFA) from 5 to 70% of CH3CN
(0.1% TFA) in 20 min at flow rate of 5 ml/min. U1 and U1-
scrambled peptides were dissolved in H2O/CH3CN solution with
TCEP to avoid S-S bridge formation and purified using a linear
gradient of ammonium formate buffer 0.1 M (pH = 7.0) and
ammonium formate buffer/CH3CN 0.1 M (pH = 7.0) (1:1 v/v)
from 20 to 65% of ammonium formate buffer/CH3CN 0.1 M
Structural Model of the hUbA1-UbcH10 Complex
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(pH = 7.0) in 25 min at flow rate of 5 mL/min. The collected
fractions containing the peptides were lyophilized. The identity
and purity of peptides were assessed by an ESI-LC-MS instrument
(ThermoFinnigan, NY, USA) equipped with a diode array
detector combined with an electrospray ion source and ion trap
mass analyzer using a Phenomenex Jupiter Proteo column
(15062 mm; 4 mm; 90 A˚) and a linear gradient of H2O (0.1%
TFA)/CH3CN (0.1% TFA) from 5 to 70% of CH3CN (0.1%
TFA) in 15 min at flow rate of 200 ml/min for L1 and L2 peptides
and from 20 to 80% of CH3CN (0.1% TFA) in 15 min for U1
peptides.
ELISA assay
Wells were coated overnight at 4uC with 100 mg/ml GST-
UbcH10 in PBS 1X, 1 mM TCEP, in the presence of an EDTA
free protease inhibitor cocktail (Roche Diagnostics). Binding step
was performed with different concentrations of biotinylated
peptides L1, L2, ScrL2, U1, ScrU1, S2 (2.2, 11, 22, 44,
108 mM) in PBS 1X (with 1 mM TCEP for U1 and ScrU1). A
blocking solution 1% BSA in PBS 1X, 0.05% Tween-20 was used.
Washes were executed with PBS 1X, 0.05% Tween-20. To verify
the interaction a 1:10000 dilution of horseradish peroxidase-
conjugated streptavidin (Sigma Aldrich) in 0.3% BSA, PBS 1X
was incubated for 1 hour. The colorimetric reaction was carried
out with SIGMA-FAST OPD reagent (Sigma Aldrich), according
to the manufacturer’s instructions. Finally, readings were per-
formed at 490 nm on a Model680 MicroplateReader (Bio-Rad,
Hercules, CA-USA), and data were recorded by Microplate
Manager 5.2 program and elaborated by GraphPad Prism
program. Negative control experiments with the fusion tag GST
in coating were performed in the same conditions described above.
Results and Discussion
In order to determine the 3D model of the tetrameric complex
responsible for UbcH10 transthiolation and identify the regions
involved in protein recognition, we have first built the trimeric
complex formed by UbA1 with two Ubs, one covalently bound at
UbA1 Cys632 (Ub(T)) through a thioester bond (indicated with the
symbol ,) and the other non-covalently bound at the AD site
(Ub(A)) following an incremental docking procedure that follows
the series of events leading to the quaternary system (Figure 1).
The model of the quaternary complex was then experimentally
validated by competitive binding assays using a series of peptides
chosen for their contribution to the protein-protein interface in the
3D model (see below).
Homology modeling of hUbA1
The structural model of hUbA1 was built up by using 1Z7L and
3CMM structures as templates for the hUbA1 SCCH region
(1Z7L) and for the AD, FCCH and UFD domains (3CMM),
respectively. Moreover, the two conformations of S. cerevisiae
UbA1 (scUbA1) found in the X-ray structure 3CMM were
considered, leading to 3D models named UbA1_A and UbA1_C
(see Materials and Methods). The quality of the models was
checked by considering a number of structural features, including
stereochemical properties, the compatibility between the amino
acid sequence and the environment of amino acid side chains, and
the patterns of non-bonded interactions (see Table 1). The
Ramachandran plots for the two UbA1 models showed that
around 98% of the total residues were located within the allowed
regions (88% in the most favored ones), and only 3 (UbA1_A) or 4
(UbA1_C) residues were found in disallowed regions (0.3%)
(Figure S1). The global PROCHECK G-factor for UbA1_A and
UbA1_C was 20.08 and 20.15, respectively, indicating that the
two structures are acceptable, because the recommended value
must be greater than 20.50. On the other hand, the VERIFY3D
scores above the threshold of 0.2 (86.7% and 90% for UbA1_A
and UbA1_C, respectively) also indicated good local structural
environments. Finally, the ERRAT2 analysis, which examines the
quality of non-bonded interactions, yielded an estimate above
95%, indicating that the two models exhibit interresidue contacts
that compare well with the patterns observed in high-resolution
structures.
Taking into account the similar scores obtained for the two
models and their structural resemblance (RMSD = 1.2 A˚), MD
refinement was accomplished only for UbA1_C. A stable structure
was obtained after the first 5 ns of the trajectory (Figure S2; A).
The increase in the RMSD was mainly due to structural
rearrangements of the domains present in UbA1, leading to an
average displacement of ca. 6 A˚. Nevertheless, the structure of
each domain was very stable along the trajectory, as demonstrated
by the stability of the RMSD of the single domains (Figure S2; B).
hUbA1,Ub(T) and hUbA1,Ub(T)-Ub(A) complexes
To build up the tetrameric complex between hUba1, Ub(T),
Ub(A) and UbcH10, we first modeled the hUbA1,Ub(T)
thioester complex, which was subsequently used to dock a second
Ub molecule in the AD domain. Modeling the binding mode of
Ub(T) is challenged by the lack of structural and biochemical
information about this interaction, and by the covalent linkage of
Ub, which is an unusual feature in protein-protein docking. To
this end, a multistep strategy that included the use of two protein-
protein docking webservers, HADDOCK and RosettaDock, in
order to disclose the non-covalent interfaces between the E1 and
Ub(T), was adopted. Accordingly, we first docked Ub to hUba1
using HADDOCK by restraining the contact between Cys632
(UbA1) and Gly76 (Ub). Among the 9 clusters that embody the
200 best structures yielded by HADDOCK (Table S2), solutions
were chosen on the basis of four criteria: i) the distance from the
sulfur atom of Cys632 and the carboxylic oxygen of Gly76, ii) the
total score, iii) the total number of poses, and iv) the buried surface
area. The selected poses lead to a distance lower than 3.8 A˚, and
are characterized by a high score, a large number of poses, and a
large burial of surface area (see Table S2). These poses (denoted
Ha and Hb) mainly differ in the orientation of Ub relative to the
SCCH domain (Figure 2-A). In the lowest energy solution (Ha),
Ub forms contacts with SCCH, mainly through ionic and polar
interactions, and FCCH, primarily through hydrophobic interac-
tions via the Ile44 patch, which is known to be involved in other
non-covalent interactions of Ub, such as in the recognition of
UbcH5c, UEV and GLUE domains [39]. In the second pose (Hb),
Ub only showed polar contacts between residues in the Ub tail
with the SCCH domain.
The two poses were then checked using RosettaDock. The best
ranked solution turned out to be very similar to the best
HADDOCK solution (Ha), as noted in a RMSD of 0.82 A˚. In
contrast, calculations started from pose Hb yielded solutions that
showed significant structural differences with regard to the initial
structure. Therefore, due to the structural consistency of pose Ha,
it was chosen as a model of the hUbA1,Ub(T) complex and
subsequently refined by MD simulations, which led to a stable
trajectory after the first 2 ns (see Figure S2-A, C). The refined
structure supports the hydrophobic contacts between residues
Leu8, Ile44, Val70 and Leu73, which interact with FCCH
residues Y286, Met223, Val277, Leu178 and Thr233. The
hydrophobic interactions involving the Ile44 patch were also
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reinforced by ionic interactions between Arg42 (Ub(T)) and
Asp236 and between Arg74 (Ub(T)) and Asp811 (Figure 2-B).
The trimeric complex was obtained through docking of Ub to
the AD site and subsequent MD refinement, which led to a stable
trajectory after the first 2 ns (see Figure S2-A, D). The 3D
structures closely resembled the X-ray template 3CMM (RMSD of
1.1 A˚; Figure 3A). Three different interfaces might be identified: i)
the loop pocket defined by hUbA1 residues Tyr618, Ser621,
Glu626, Arg515, Asn512, Asn516 and Arg551 interacting with
Ub(A) tail residues Arg72, Arg42 and Arg74 and AMP (Figure 3,
B); ii) an hydrophobic patch formed by the Ub residues Leu8,
Ile44 and Val70 that form contacts with an hydrophobic area in
the hUbA1 AD region formed by residues Phe933 and Phe926
(Figure 3-C); and iii) the polar interface formed by Ub(T) residues
Thr9, Lys11, Thr12, Asp3 interacting with the FCCH region,
mainly with residues Glu243, Arg239 and Asn212 (Figure 3-C).
Moreover, interactions between Ub(T)-Lys48 and Asp920 and
Glu938, not present in the 3CMM structure, were also found.
Finally, during the submission of the article, a novel structure of
the scUbA1 loaded with two ubiquitin molecules was released in
the PBD with the name 4NNJ [40]. The superimposition of the
model of hUbA1-Ub(T)-Ub(A) complex obtained with our
incremental strategy to the crystal structure (chains C,D,E) leads
to an rmsd of 1.5 A˚ (determined for the Ca carbon atoms), and
showed a position of Ub(T) very similar to the pose C_Ha selected
Table 1. Structural models of hUbA1.
Protein Procheck
1 Errat2 Verify3D
Most favoured Allowed regions Generously allowed Disallowed % %(avg.0.2)
CMM_A 780 (88.1%) 98 (11.1%) 1 (0.1%) 6 (0.7%) 91.8 88.0
hUbA1_A 781 (87.9%) 93 (10.5%) 12 (1.3%) 3 (0.3%) 95.8 86.7
CMM_C 787 (88.3%) 90 (10.1%) 7 (0.8%) 7 (0.8%) 96.4 94.0
hUbA1_C 789 (88.6%) 95 (10.7%) 3 (0.3%) 4 (0.4%) 95.6 90.0
Validation results for the lowest energy models of hUbA1, compared with the corresponding templates.
1Number of residues in the region (the percentage is given in brackets).
doi:10.1371/journal.pone.0112082.t001
Figure 2. Model of hUbA1-Ub(T) complex. A) Comparison of the best two binding modes of Ub resulting from HADDOCK calculation, Ha and
Hb, shown in yellow and orange, respectively. Terminal Ub-Gly76 and catalytic UbA1-Cys632 are highlighted in spheres coloured by atom type. B)
Detail of hUbA1,Ub(T) interactions in the lowest energy MD frame (time 9.6 ns). Apolar hydrogens were omitted for sake of clarity. Colour code:
hUbA1, grey; Ub(T), yellow; van der Waals interactions are highlighted with transparent Connolly surfaces. Carbons are in cyan, nitrogen in blue,
oxygens in red, sulphur in yellow and hydrogens in white.
doi:10.1371/journal.pone.0112082.g002
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in our calculations (Figure S3), thus supporting the reliability of
our model.
hUbA1,Ub(T)-Ub(A)-UbcH10 complex
The hUbA1,Ub(T)-Ub(A) model was the starting point for the
docking with UbcH10. In order to make a more exhaustive
sampling, up to four different starting points were considered for
docking calculations (see Materials and Methods). HADDOCK
calculations yielded 80 clusters. The results were filtered by
selecting only poses where the distance from the sulphur atom of
the UbcH10 catalytic cysteine (Cys114) to the carbonyl carbon of
the C-terminal Gly in Ub(T) was lower than 20 A˚, considering this
limit as indicative of the side of UbcH10 facing the SCCH region.
Moreover, this criterion is consistent with the distance between the
Cys residues involved in the transthiolation reaction in the crystal
structure 2NVU, representing the tetrameric complex of the
NEDD8 system. Only six clusters satisfied the distance cutoff.
Among these clusters, Ub(T) adopted the Ha binding mode in five
cases, and the Hb arrangement was found in a single case. This
suggests that the Ha binding mode position was better suited to
accommodate the E2 partner within the E1 groove with the
catalytic cysteines facing each other. Table 2 shows the distinct
poses ranked according to HADDOCK score as well as to the
binding free energy of the complex calculated with the SIE
Figure 3. Model of hUbA1-Ub(T)-Ub(A) complex. A) Superimposition of the hUbA1,Ub(T)-Ub(A) model C_Ha on the crystal structure 3CMM_C;
B) Detail of the main interactions of Ub(A) and AMP in the hUbA1 loop pocket; C) Detail of the main interactions between Ub(A) and hUbA1:
hydrophobic and polar interface. AMP is highlighted in CPK. Apolar hydrogens were omitted for sake of clarity. Colour code: hUbA1, grey; Ub(T)
yellow; Ub(A), orange; scUbA1, blue; scUb(A), green.
doi:10.1371/journal.pone.0112082.g003
Structural Model of the hUbA1-UbcH10 Complex
PLOS ONE | www.plosone.org 7 November 2014 | Volume 9 | Issue 11 | e112082
method using the snapshots collected in the MD simulation.
A_Ha_L2 emerges as the best pose according to HADDOCK
score and SIE binding affinity. Both HADDOCK and SIE scores
are consistent in suggesting C_Ha_R and C_Ha_L as feasible
poses. The structures of these complexes differ by around 5.5 A˚
relative to A_Ha_L2. The A_Ha_L1 and A_Ha_R poses were
structurally similar to A_Ha_L2 (rmsd of 3.3 A˚) and Ca_Ha_R
(rmsd of 4.3 A˚), respectively. However, SIE calculations predict
that they are less stabilized compared to A_Ha_L1 and A_Ha_R.
Finally, C_Hb_R was rejected due to their low energetic score.
It is experimentally known that the N-terminal helix and b1b2
loop of E2 are directly involved in the formation of the complex
[13,31,41–43]. In particular, mutational and structural studies
disclosed the main role of two basic residues, conserved in the E2
family (positions 33 and 37 in UbcH10 numbering), in assisting the
binding to E1. We have therefore examined the role played in the
selected models by i) the conserved acidic residues of the UFD
region of hUbA1 (i.e. Glu1037, Asp1047 and Glu1049) and ii) the
conserved basic residues of the N-terminal helix of UbcH10 (i.e.
Lys339 and Gln379). It is worth noting that while a basic residue in
position 33 is conserved in all the members of the E2 family,
position 37 shows a higher variation, albeit basic or polar residues
are generally found in this position. To this end, the best three
solutions (A_Ha_L2, C_Ha_R and C_Ha_L) were subjected to a
virtual alanine scanning analysis in order to evaluate the
contribution of these residues to the E1–E2 interaction. Even
though the results (Table 3) did not show significant interactions
(defined as DDG $20.5 kcal/mol) with Gln379, the best three
models showed a significant contribution to the binding of at least
one residue from the N-terminal helix and one residue from the
UFD region of UbA1. For the sake of comparison, no significant
contribution was found for the mutations in the N-terminal helix
for poses A_Ha_L1 and A_Ha_R. In fact, only a single mutation
in hUbA1 (Asp1047RAla) was found to lead to a significant
destabilization. This finding, together with the structural resem-
blance to A_Ha_L2 and Ca_Ha_R and the lower SIE binding free
energy (see above), led to their exclusion from further refinements.
The three models were further refined by running a series of
50 ns MD simulations, and the binding free energy was
determined from SIE calculations performed for the snapshots
sampled in the last four 10 ns windows. The results consistently
showed that the best binding affinity was obtained for model
C_Ha_R (226.660.2 kcal/mol), it being more favorable by 6 and
9 kcal/mol compared to A_Ha_L (220.261.4 kcal/mol) and
C_Ha_L (217.261.5 kcal/mol) models. On the basis of the
preceding findings, the C_Ha_R model was further refined by
extending the MD simulation to 500 ns. The analysis of the
trajectory revealed a progressive stabilization of the complex,
leading to a binding affinity close to 231 kcal/mol in the last
250 ns (Figure 4-A). The alanine scanning analysis also demon-
strated that the residues known to be critical to E1–E2 complex
formation contributed significantly to the protein-protein interac-
tion with the only exception of Gln379 (Figure 4-B). During the
MD run we observed a change in hUbA1 associated to the
rotation in opposite directions of the UFD and SCCH domains
with respect to the AD domain (by 20u and of 13u, respectively, as
calculated with DynDom [44]). This conformational change
caused the widening of the groove defined by the three domains,
thus allowing a closer contact between hUbA1 and UbcH10,
leading to an increase of the interaction surface (Table S3) and the
gradual decrease of the distance between the UbcH10 catalytic
cysteine and the Ub(T) C-terminal glycine crosslinked to UbA1-
Cys632 until it stabilised at around 8 A˚ (Figure S4). Analysis of the
last 50 ns of the trajectory revealed the presence of two main
interaction surfaces, which involve contacts between i) UbcH10
helix H1 and b1b2 loop and hUbA1 UFD domain, and ii) the
hUbA1 Cys-cap loop and Ub(T) (Figure 5).
Final refinement of the tetrameric complex
Although MD simulations led to a progressive refinement of the
quaternary complex, the distance between residues Cys114 in
UbcH10 and the terminal glycine of the crosslinked Ub(T) was still
too large (,8 A˚; Figure S4) as to mimic a state that resembles the
catalytic arrangement of the interacting proteins. Inspection of the
final MD structure showed that a closer approach between hUbA1
and UbcH10 was prevented by the Cys-cap loop, which retained
the orientation found in the PDB template 3CMM. In contrast, in
the available structure of the E1–E2 complex (PDB structure 4II2)
the Cys-cap loop is not assigned, thus suggesting a large flexibility
in the covalent construct that mimics the thioester crosslinking
event. We have therefore forced the approach of UbcH10 by using
steering forces applied on the sulphur of the UbcH10 Cys114
toward the carbonyl group of the crosslinked Ub(T) C-terminal
glycine, after manual removing of the Cys-cap loop. SMD
simulations allowed us to reduce the distance between those
atoms from 8 A˚ to 3.2 A˚ in 8 ns. After loop reconstruction, the
final structure was refined in a 50 ns MD simulation, leading to a
stable trajectory (Figure S5). This approach led to a closer fitting of
UbcH10 into the groove defined by the UFD and SCCH domains,
increasing the total interaction surface, especially between
hUbcA1 SCCH and the UbcH10 region around the catalytic
cysteine, in better agreement with the crystal structure of the E1–
E2 crosslinked construct (Table S3). Moreover, SIE calculations
revealed an increase of the binding energy to 242.7 kcal/mol.
Comparison of the refined model with the recently reported X-
ray crystallographic structure of the trimeric complex of S. pombe
Table 2. Comparison of structural and energy data for selected docking results of the quaternary complex.
Docking UbcH10 S-C114 HUbA1 S-C632 UbcH10 S-C114 Ub(T) C-ter G76 Haddock Score SIE DG
A_Ha_L2 15,2 17,6 2147.7611.2 211.0
C_Ha_R 14,6 14,5 2126.765.4 29,6
C_Ha_L 18,1 17,4 2125.065.4 29,2
A_Ha_L1 16,9 15,1 2118.967.3 28.0
A_Ha_R 11,3 11,8 2125.0610.0 27,6
C_Hb_R 16,7 18,5 296.668.3 23,6
The structural data include the distance (A˚) from the sulphur of the UbcH10 Cys114 to the hUbA1 Cys632, and to the C-terminal Gly76 of Ub(T). The energy data report
the score of the docked structures obtained from HADDOCK and from SIE (kcal/mol).
doi:10.1371/journal.pone.0112082.t002
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Uba1-Ub-Ubc4 (PDB ID: 4II2) lends support to the theoretical 3D
model of the quaternary complex. Thus, after deletion of the E2
partners (UbcH10 and Ubc4) and the additional Ub present in the
quaternary complex, superposition of the backbone Ca carbon
atoms leads to a positional rmsd of 2.5 A˚, which indicates the
similar structural arrangement of the AD, SCCH and UFD
domains in the two complexes (see also Figure S6). Furthermore,
retention of the E2 partners in the superposed structures leads to
an rmsd value of 2.6 A˚, thus suggesting a similar arrangement in
the trimeric and quaternary complexes.
The analysis of the snapshots sampled in the last 20 ns of the
trajectory allowed us to identify key interactions in the complex,
which involve three interfaces: i) the contacts between the hUbA1
UFD domain and the UbcH10 helix H1 and b1b2 loop, ii) the
interaction between the hUbA1 SCCH domain and Ub(T) with
the region surrounding the UbcH10 Cys114’, involving residues
from the 3–10 helix and helices H2 and H3, and iii) the contacts
between the hUbA1 crossing loop and Ub(A) with UbcH10.
The first interface (Figure 6) comprises the UbcH10 residues
Lys339 and Gln379, which are experimentally known to be critical
for the interaction between E1 and E2 [41–43]: Lys339 interacts
with Asp1042 and with Ser1044, and Gln379 is hydrogen-bonded
to the backbone oxygen of Cys1040 and the hydroxyl group of
Thr988 (Figure 6-F). Moreover, hydrogen bonds were also formed
between the side chains of Gln36’ and Asp1042, between Tyr91
and Asp1047, and between the N-terminal Pro309 with Glu1049
(Figure 6-F). Finally, the ionic interactions were supplemented by
hydrophobic contacts involving hUbA1 residues Met989, Val994,
Met996, Phe1000, Phe1001, and UbcH10 residues Leu429,
Pro549, Leu599 and Phe609 (Figure 6-E).
Interactions between the hUbA1 SCCH domain and the region
surrounding the E2 catalytic cysteine were mainly characterized
by a number of ionic and polar interactions between residues from
H3 and H4 helices of UbcH10 (Glu154’, Lys164’, Lys172’ and
Tyr165’) and residues from the hUbA1 Cys-cap loop (Gln728,
Lys806, Glu813, Asp811 and Asp822) (Figure 6-B), while the
region around the UbcH10 catalytic cysteine, including residues in
the 3–10 helix, were involved in interactions with the residues
around hUbA1 Cys632 and Ub(T). In particular, two main
clusters of interactions are formed: i) the first, mainly based on
hydrophobic interactions, between the UbcH10 helix H3
(Pro1479, Ala1539 and T1509) with the UbA1 coiled stretch
between H24 and H25 (Phe637, Phe729 and Phe741), also
supported by hydrogen bonds between Asn728 with His1519 and
Thr1509 (Figure 6-C); ii) the second mainly involves residues
closer to the catalytic cysteines, such as the ionic contact between
the UbcH10 Asp1459 with UbA1-Lys746 and Ub(T)-Arg 72, and
interactions between charged residues in the UbcH10 3–10 helix
(Asp1169, Asp1209 and Lys1219) with Ub(T) residues (Gln40,
Table 3. Alanine scanning.
Docking DDG hUbA1 DDG UbcH10
E1037A D1047A E1049A K33A N37A
A_Ha_L2 0.0 20.8 0.0 20.8 20.4
C_Ha_R 20.2 20.4 21.5 20.7 0.0
C_Ha_L 20.3 21.3 0.1 21.0 20.1
A_Ha_L1 0,0 21,2 0,0 20,2 20,2
A_Ha_R 20,2 20,6 0,0 20,3 0,1
C_Hb_R 20,4 0,2 20,6 20,7 0,0
Results of the virtual alanine scanning (DDG; kcal/mol) due to the mutation to Ala of residues Glu1037, Asp1047 and Glu1049 in hUbA1 and Lys339 and Gln379 in
UbcH10 are reported.
doi:10.1371/journal.pone.0112082.t003
Figure 4. Energetic analysis. A) SIE values (kcal/mol) determined for the E1-E2 interaction along the trajectory (averaged for 20 ns windows). B)
Contribution of key residues as derived from alanine scanning in UbcH10 N-terminal helix and the hUbA1 UFD region during the MD simulation of
the model C_Ha_R. Colours: Glu1037, orange; Asp1047, violet; Glu1049, light green; Lys339, bordeaux: Gln369, blue; Gln379, dark green.
doi:10.1371/journal.pone.0112082.g004
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Arg74, Asp39) and with the hUbA1 FCCH domain (Glu237)
(Figure 6-D).
These findings demonstrated that the crosslinked Ub plays a key
role in the transthiolation intermediate with UbcH10. In
particular, MD simulations highlighted that the approach of the
catalytic cysteines induced a rotation of 25u of Ub(T) with respect
to hUbA1 and a rearrangement of the Ub(T) pattern of
interactions showed in models lacking E2 (Figure 7). In particular,
in absence of E2 Arg74 was hydrogen-bonded to Cys-cap residues
(Asp811 and Gln812), while in the final model it was involved in
ionic interactions with UbcH10-Glu1209 and Asp1169, and with
Glu237, bearing to the hUbA1 FCCH domain. These data
support the hypothesis that products of the transthiolation reaction
might be released upon a process involving the rearrangement of
the Ub(T) binding to E1, driven by the charged residues in the
region surrounding the catalytic cysteine of E2. Finally, we also
observed some interactions in the loop region of hUbA1, in
particular hydrogen bonds between the side chain of Asn622 with
the backbone of UbcH10-Tyr 919 (Figure 6-F), and between the
backbone of Ser628 and the side chain of Glu120’ (Figure 6-D). A
representative snapshot of the 3D model is available as supple-
mental PDB file.
Peptide affinity assays
On the basis of the 3D model of the quaternary complex, we
have designed six peptides as molecular probes in order to
calibrate their ability to interfere the binding of UbcH10. This
Figure 5. Model of the hUbA1-Ub(T)-Ub(A)-UbcH10 complex. A) Average structure of last 20 ns of MD simulation of the C_Ha_R model. The
catalytic cysteines, the thioester bond and AMP were highlighted in spheres. Detail of interactions between B) UbcH10 and SCCH region, C) UbcH10
and Ub(T) and D) UbcH10 and UFD region. Catalytic cysteins and the thioester bond were highlighted in CPK. Apolar hydrogens were omitted for the
sake of clarity. Colour code: hUbA1, grey; scUbA1, blue; Ub(T) yellow; Ub(A), orange; UbcH10, violet. The van der Waals interactions are highlighted
with transparent Connolly surfaces.
doi:10.1371/journal.pone.0112082.g005
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strategy was motivated by two main reasons. First, the identifica-
tion of short peptides that mediate protein-protein interaction
seemed a priori effective for disrupting the protein-protein
recognition and binding. While other strategies, i.e. introduction
of specific mutations, may also be envisaged, it is unclear whether
single-point mutants might lead to a significant destabilization of
the complex or even to impede the formation of the quaternary
complex. Second, since our ultimate goal is the design of
compounds that might disrupt the ubiquitilation process, testing
a series of suitably chosen short peptides represents a valuable
proof-of-concept for supporting the potential therapeutic effect of
peptidomimetics. Specifically, the peptides were designed to
examine the capability of hUbA1 stretches that contribute to the
protein-protein interface with UbcH10 (Figure S7). In particular,
we have designed two peptides per interface, which will be
denoted S for SCCH region, L for cross loop, and U for UFD
(Table 4). In the UFD region peptides U1 and U2 were selected to
test the relevance of the acidic residues in mediating the binding of
the UbcH10 H1 helix. In the SCCH region peptide S1 was chosen
to test the role of the Cys-cap in binding UbcH10, while peptide
S2, corresponding to helix H19 in the SCCH region, was designed
as negative control, since the 3D model revealed the lack of any
interaction in the complex. Finally, peptides L1 and L2 were
chosen to explore the role of the cross loop region in assisting the
interaction with UbcH10. All the peptides were synthesized as
biotinylated derivatives by solid phase method and purified by RP-
HPLC. Unfortunately, S1 and U2 were insoluble and so not
testable in binding assays. The ability of the soluble peptides to
bind recombinant GST-UbcH10 was checked by ELISA, utilizing
GST as control (data not shown).
The best results (Table 4) were obtained with U1 and L2, which
were found to bind UbcH10 with an apparent KD of about 10 and
20 mM, respectively. In order to confirm that the binding of U1
and L2 peptides was sequence-dependent, two scrambled peptides
were synthesized, ScrU1 and ScrL2. The results demonstrated that
these peptides exhibited a very poor binding, much weaker than
U1 and L2, which might then be considered indicative of native
protein-protein interactions. In particular the good affinity showed
by U1 allowed us to validate the role of the acidic residues of the
UFD region in binding E2, thus giving confidence to our 3D
model. The U1 peptide, indeed, contained D1047 and E1049, two
of the three acidic residues involved in the hUbA1 UFD-UbcH10
H1 interface. Unfortunately, the low solubility of U2 did not allow
us to verify the role of E1037, which is the third residue proven to
be involved in the interaction by mutagenesis studies. Similarly,
the results obtained for L2 support the role of Gln622 in assisting
the interaction of the crossover loop with UbcH10, in agreement
with the 3D model. The low affinity showed by L1 peptide, which
contains Gln622 at the N-terminus side of the sequence, might be
indicative of the importance of flanking residues in L2 binding.
Finally, the results obtained from the SCCH peptides allowed us to
exclude a role in the binding of the helix region corresponding to
S2, as expected for this peptide, which was designed as negative
control.
Overall, the results support the involvement of the selected
peptides in mediating the protein-protein interactions in the
hUbA1,Ub(T)-Ub(A)-UbcH10, which in turn reinforces the
reliability of the 3D model built up for the quaternary complex
between E1, E2 and Ub partners. On the other hand, they also
demonstrate the feasibility of interfering the formation of the
complex, which paves the way to the structure-based design of
peptidomimetics for UbcH10-related anticancer strategies.
Conclusions
We have simulated the dynamic process associated to the
formation of the complex leading to the transthiolation reaction
between doubly loaded hUbA1 and UbcH10. The formation of
the complex takes place through protein-protein interactions in
three main interfaces: i) the first between the hUbA1 UFD domain
and the UbcH10 helix H1 and b1b2 loop, ii) the second formed by
the hUbA1 SCCH domain and Ub(T) with the region surround-
ing the UbcH10 Cys114’, involving residues from the 3–10 helix
and helices H2 and H3, and iii) the third between the hUbA1
crossing loop and Ub(A) with UbcH10. The involvement of these
regions has been supported by the ELISA assays performed for a
series of short peptides that encompass the residues that mediate
the interaction between UbA1, UbcH10 and the two Ubs. In
particular, peptides U1 and L2, pertaining to the UBA1 UFD
domain and to the UbA1 loop, have been able to interfere the
assembly of the E1–E2 complex. The availability of this structural
model should facilitate the understanding of the structural details
of the ubiquitination cascade, to rationalize the details of the
recognition between E1 and E2 partners, and finally to facilitate
Figure 6. Final refined model of the tetrameric complex. A) Average structure of the last 20 ns of MD simulation of the model after SMD. B)
Detail of the UbcH10-Cys-cap loop interactions. C) Detail of UbcH10-Cys region involved in hydrophobic interactions; D) Detail of the UbcH10-Cys
region involved in polar interactions; E) Detail of the hydrophobic interactions between hUbA1 UFD and UbcH10. F) Detail of the polar interactions
between hUbA1 UFD and UbcH10. Colour code: hUbA1, grey; Ub(T) yellow; Ub(A), orange; UbcH10, violet. Catalytic cysteins were highlighted in
spheres. Apolar hydrogens were omitted for the sake of clarity. The van der Waals interactions are highlighted with transparent Connolly surfaces.
doi:10.1371/journal.pone.0112082.g006
Figure 7. Rotation of the Ub(T) induced by UbcH10 interaction
in the final quaternary model with respect to the UbA1,Ub(T)
model. Superimposition was made on the Ca atoms of the SCCH and
FCCH domains. Colour code: Final quaternary complex model: hUbA1,
grey; UbA1,Ub(T) model: UbA1, black; Ub(T), magenta; Arg74 in the
two models is shown as licorice. Apolar hydrogens were omitted for
sake of clarity.
doi:10.1371/journal.pone.0112082.g007
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the design of peptidomimetics or small size compounds able to
interfere with the formation of the E1–E2 complex, which might
be valuable to open new strategies against tumorigenic processes.
Supporting Information
Figure S1 Comparison of the Ramachandran plot of the
models A (A) and C (C) with the corresponding
conformations of the template 3CMM (B and D respec-
tively).
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Figure S2 A: Time evolution (ns) of the RMSD (A˚) of the
UbA1_C model: hUbA1 apo (red), hUbA1,Ub(T) (yellow),
hUbA1,Ub(T)-Ub(A) (green) and hUbA1,Ub(T)-Ub(A)-
UbcH10 (black). B, C and D: Structural preservation of the
structure of each region. of: hUbA1 apo (B), hUbA1-Ub(T) (C)
and UbA1,Ub(T)-Ub(A) (D), AD (black), UFD (green), SCCH
(red) and FCCH (blue).
(TIFF)
Figure S3 Superposition of the backbone for the X-ray
structure 4NNJ and the 3D model of the ternary
complex. Front and side views are shown in the left and right
pictures, respectively. Colour code: hUbA1, grey; Ub(T) yellow;
Ub(A), orange; scUbA1, magenta scUb(A), green, scUb(A), Cyan.
(TIFF)
Figure S4 Analysis of the distance between the sulphur
atom of the UbcH10 Cys114 and the carbonyl group of
the crosslinked Ub(T) terminal glycine during the 500 ns
unconstrained MD.
(TIFF)
Figure S5 Analysis of the distance between the sulphur
of the UbcH10 Cys114 and the carbonyl group of the
crosslinked Ub(T) C-terminal glycine during the 50 ns
unconstrained MD of the final model obtained after
SMD.
(TIFF)
Figure S6 Superposition of the UbA1 and Ub(A) back-
bone for the X-ray structure 4II2 (grey) and the 3D
model of the quaternary complex (Green). Front and rear
views are shown in the left and right pictures, respectively.
(TIFF)
Figure S7 Strategy of peptide design, highlights of the
hUbA1 regions used to design the peptides. Colour code:
hUbA1, grey; Ub(T) yellow; Ub(A), orange; UbcH10, violet; S1
and S2 red; U1 and U2 green; L1 and L2 blue.
(TIF)
Table S1 List of the active residues used in each
docking step.
(DOCX)
Table S2 Results from HADDOCK calculations per-
formed for the dimeric hUbA1 and Ub(T) complex.
Clusters of poses are given ordered by total score. The best models
are highlighted in bold.
(DOCX)
Table S3 Time evolution of interaction surface (A˚2) for
selected domains in hUbA1.
(DOCX)
File S1 Atomic Coordinates of a representative snap-
shot of the 3D model.
(PDB)
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